Use of TLR-2 antagonists for treatment of reperfusion injury and tissue damage

Details for Australian Patent Application No. 2008285626 (hide)

Owner Opsona Therapeutics Limited

Inventors Pasterkamp, Gerard; O'Neill, Luke; McGuirk, Peter; Locher, Christopher; De Kleijn, Dominique; Heffernan, Mark; Arslan, Fatih; Keogh, Brian

Agent Shelston IP

Pub. Number AU-A-2008285626

PCT Pub. Number WO2009/019260

Priority 61/038,555 21.03.08 US; 2007/0558 03.08.07 IE

Filing date 4 August 2008

Wipo publication date 12 February 2009

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

4 February 2010 PCT application entered the National Phase

  PCT publication WO2009/019260 Priority application(s): WO2009/019260

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008285636-Burner

2008285608-Heat-resistant composition for animals, comprising an enzymatic mixture